Cue Biopharma (CUE) CEO sells 58,258 shares to cover tax on vested awards
Rhea-AI Filing Summary
Cue Biopharma, Inc.’s Chief Executive Officer Shao-Lee Lin reported transactions in Common Stock linked to equity awards. On August 12, 2026, 109,179 performance stock units vested and settled into common shares, representing the first third of a PSU award tied to stock-price hurdles. On August 12–13, 2026, Lin sold an aggregate 58,258 shares at weighted-average prices between $26.50 and $29.87; footnotes state these were block trades executed as “sell-to-cover” transactions to satisfy tax withholding obligations on restricted stock unit vesting and are not discretionary trades. The remaining two-thirds of the PSU award may settle upon achieving closing share prices of $38.50 and $44.00 for five consecutive trading days within 24 months of grant.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Lin Shao-Lee
Role
Chief Executive Officer
Sold
58,258 shs ($1.61M)
Approx. gross sale proceeds
$1.61M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F4 | 5,423 | $27.19 | $147K |
| Sale | Common Stock F1, F5 | 2,375 | $28.11 | $67K |
| Sale | Common Stock F1, F6 | 10,460 | $29.48 | $308K |
| Exercise | Common Stock F7 | 109,179 | $0.00 | $0.00 |
| Exercise | Common Stock | 109,179 | $0.00 | $0.00 |
| Sale | Common Stock F1, F2 | 34,225 | $26.99 | $924K |
| Sale | Common Stock F1, F3 | 5,775 | $27.75 | $160K |
Holdings After Transaction:
Common Stock — 924,353 shares (Direct)
Footnotes (7)
- F1. The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.
- F2. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $26.50 to $27.495, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F3. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $27.50 to $28.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F4. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $26.70 to $27.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F5. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $27.78 to $28.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F6. The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.90 to $29.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.
- F7. The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 12, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.
Key Figures
Shares sold: 58,258 shares
Performance stock units vested: 109,179 PSUs
Sale price range: $26.50–$29.87 per share
+2 more
5 metrics
Shares sold
58,258 shares
Aggregate common shares sold by the CEO on August 12–13, 2026
Performance stock units vested
109,179 PSUs
PSUs that vested and settled into common stock on August 12, 2026
Sale price range
$26.50–$29.87 per share
Weighted-average price ranges for block trades referenced in footnotes F2–F6
PSU price targets
$33.00, $38.50, $44.00
Closing price per share targets required for three PSU vesting tranches
Performance period
24 months
Period from grant during which PSU stock-price targets must be achieved
Key Terms
sell-to-cover, restricted stock units, performance stock units, weighted average price, +1 more
5 terms
sell-to-cover financial
"shares sold by the Reporting Person to cover tax withholding obligations in connection"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
restricted stock units financial
"tax withholding obligations in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance stock units financial
"The performance stock units ("PSU") were awarded subject to certain stock-price based"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
weighted average price financial
"The price reported in this line item is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transactions did Cue Biopharma (CUE) report for its CEO?
Cue Biopharma reported that CEO Shao-Lee Lin had 109,179 performance stock units vest into common stock and sold 58,258 shares. The share sales occurred on August 12–13, 2026, in connection with equity award vesting and related tax obligations.
Were the Cue Biopharma (CUE) CEO’s stock sales discretionary trades?
No. Footnotes state the CEO’s reported sales represent shares sold to cover tax withholding obligations from restricted stock unit vesting. They are described as “sell-to-cover” transactions and are characterized as not discretionary by the reporting person.
What are the terms of the Cue Biopharma (CUE) performance stock units reported?
The performance stock units vest in three tranches based on stock-price targets of $33.00, $38.50, and $44.00, each requiring five consecutive trading days. If targets are not met within 24 months from grant, the unsatisfied PSUs are forfeited.
How much of the Cue Biopharma (CUE) PSU award has vested for the CEO?
As of August 12, 2026, one-third of the CEO’s performance stock unit award, totaling 109,179 PSUs, has vested and settled into common shares. The remaining two-thirds may settle upon meeting higher stock-price hurdles within the specified performance period.
Did Cue Biopharma (CUE) report any remaining performance conditions for the CEO’s PSUs?
Yes. The remaining two-thirds of the CEO’s PSUs are expected to settle only if Cue Biopharma’s stock reaches closing prices of $38.50 and $44.00 for five consecutive trading days within 24 months from the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
